Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Citigroup Maintains Sell on Palantir Technologies, Lowers Price Target to $5

Citigroup Maintains Sell on Palantir Technologies, Lowers Price Target to $5

Citigroup analyst Tyler Radke maintains Palantir Technologies (NYSE:PLTR) with a Sell and lowers the price target from $6 to $5.

byBenzinga Newsdesk

November 11, 2022

1 minute read

Citigroup analyst Tyler Radke maintains Palantir Technologies (NYSE:PLTR) with a Sell and lowers the price target from $6 to $5.

Harmony Biosciences, Futu Holdings, iHeartMedia And Other Big Stocks Moving Lower On Tuesday

By Lisa Levin

March 28, 10:30 AM

U.S. stocks traded mixed, with the Dow Jones gaining around 100 points on Tuesday. Here are some big stocks recording losses in today’s session.

AMPX

M&A
News

Extra Space And Life Storage Stockholders Approve Merger

By Benzinga Newsdesk

July 18, 4:22 PM

According to the results of the Extra Space Special Meeting of Stockholders, more than 99.9 percent of votes cast at the meeting – approximately 90.3 percent of the outstanding shares of Extra Space common stock as of

EXR

Equitrans Midstream Net Income Outlook: FY23 $330M – $410M, Q2 $30M – $50M

By Benzinga Newsdesk

May 2, 6:41 AM

Full-Year 2023 Financial Outlook(1) $ millions With MVP(2) Without

ETRN

P/E Ratio Insights for Genmab

By Benzinga Insights

April 11, 3:00 PM

In the current session, the stock is trading at $38.92, after a 0.22% spike. Over the past month,…

GMAB

Citigroup Maintains Sell on Palantir Technologies, Lowers Price Target to $5

Related Posts

Harmony Biosciences, Futu Holdings, iHeartMedia And Other Big Stocks Moving Lower On Tuesday

Extra Space And Life Storage Stockholders Approve Merger

Equitrans Midstream Net Income Outlook: FY23 $330M – $410M, Q2 $30M – $50M

P/E Ratio Insights for Genmab